Literature DB >> 12498926

Adenosine A1 receptor blockade reverses experimental postoperative ileus in rat colon.

Makoto Kadowaki1, Yasunori Nagakura, Kenichi Tokita, Kaori Hanaoka, Masaaki Tomoi.   

Abstract

Inhibition of colonic propulsive motility is the main contributor to postoperative ileus in humans. Experimental models for investigating colonic propulsion in surgically induced postoperative ileus have not previously been available. This study was designed to assess whether adenosine A(1) receptor antagonists (R)-1-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl) acryloyl]-piperidin-2-yl acetic acid (FK352) and 8-cyclopentyl-1, 3-dipropylxanthine (DPCPX) reverse the colonic motility disorder in newly developed rat experimental ileus models. When rats underwent anesthesia (pentobarbital) or surgical traumas (partial gastrectomy, cecectomy or gentle touching of the colon with fingers), colonic propulsive motility was evaluated by migration of intracolonically injected dye in awake unrestrained rats. Propulsive motility resulted in significant decrease after the treatment of the anesthesia or partial gastrectomy. Intravenous administration of either adenosine A(1) receptor antagonist reversed the slowed colonic propulsion in these experimental ileus models. The present study suggests that the blockade of adenosine A(1) receptors has therapeutic potential for postoperative ileus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12498926     DOI: 10.1016/s0014-2999(02)02766-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Enteric nervous system in the small intestine: pathophysiology and clinical implications.

Authors:  Behtash Ghazi Nezami; Shanthi Srinivasan
Journal:  Curr Gastroenterol Rep       Date:  2010-10

2.  New bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC.

Authors:  Leszek Rybaczyk; Andrew Rozmiarek; Kristin Circle; Iveta Grants; Bradley Needleman; Jacqueline E Wunderlich; Kun Huang; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

Review 3.  Potential for developing purinergic drugs for gastrointestinal diseases.

Authors:  Fernando Ochoa-Cortes; Andromeda Liñán-Rico; Kenneth A Jacobson; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2014-07       Impact factor: 5.325

4.  Purinergic receptors and synaptic transmission in enteric neurons.

Authors:  Jianhua Ren; Paul P Bertrand
Journal:  Purinergic Signal       Date:  2007-12-08       Impact factor: 3.765

5.  Purinergic mechanisms in the control of gastrointestinal motility.

Authors:  J C Bornstein
Journal:  Purinergic Signal       Date:  2007-10-06       Impact factor: 3.765

6.  Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A(2A) and extrajunctional inhibitory A(1) receptors.

Authors:  Margarida Duarte-Araújo; Carlos Nascimento; M Alexandrina Timóteo; Teresa Magalhães-Cardoso; Paulo Correia-de-Sá
Journal:  Br J Pharmacol       Date:  2004-03-01       Impact factor: 8.739

7.  Post-inflammatory Ileitis Induces Non-neuronal Purinergic Signaling Adjustments of Cholinergic Neurotransmission in the Myenteric Plexus.

Authors:  Cátia Vieira; Fátima Ferreirinha; Maria T Magalhães-Cardoso; Isabel Silva; Patrícia Marques; Paulo Correia-de-Sá
Journal:  Front Pharmacol       Date:  2017-11-08       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.